2025. Clinical Efficacy of Rifampicin Nanoparticle Local Delivery in Post-Surgical Wound Infections Caused by Resistant Bacteria. Link Medical Journal. 3, 2 (Dec. 2025), 1–11. DOI:https://doi.org/10.61919/xrpzj971.